Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0-3: evidence from CHARLS 2011-2020

Cardiovasc Diabetol. 2026 May 16. doi: 10.1186/s12933-026-03206-z. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3 represent a critical window for preventing progression to overt cardiovascular disease (CVD). Insulin resistance (IR) is central to C

Correlation between the modified cardiometabolic index and the incidence of cardiovascular disease in a population with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study

Sci Rep. 2026 May 15. doi: 10.1038/s41598-026-49385-3. Online ahead of print.ABSTRACTThe global burden of cardiovascular disease (CVD) is substantial, particularly among individuals with cardiovascular-kidney-metabolic (CKM) syndrome. This study aimed to examine the relationship between the modified

HDL and coronary artery disease

No abstractJ Clin Lipidol. 2026 Apr 30:S1933-2874(26)00130-3. doi: 10.1016/j.jacl.2026.04.024. Online ahead of print.NO ABSTRACTPMID:42140833 | DOI:10.1016/j.jacl.2026.04.024